©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2013; 19(38): 6438-6446
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6438
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6438
Table 6 Comparison of the areas under the receiver operating characteristic curve according to the type of sample (whole-tissue section and tissue microarray) and the antibodies
| Whole-tissue sections | |||||
| HercepTest | 4B5 | SP3 | |||
| AUC | 0.73 | 0.91 | 0.78 | ||
| TMAs | HercepTest | 0.71 | P = 0.572 | P = 0.001 | P = 0.013 |
| 4B5 | 0.79 | P = 0.289 | P = 0.027 | P = 0.201 | |
| SP3 | 0.80 | P = 0.265 | P = 0.034 | P = 0.244 | |
- Citation: Abrahão-Machado LF, Jácome AADA, Wohnrath DR, Santos JSD, Carneseca EC, Fregnani JHTG, Scapulatempo-Neto C. HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays. World J Gastroenterol 2013; 19(38): 6438-6446
- URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6438.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i38.6438